Continuing the Conversation on BRCA1 and BRCA2 Mutations

What are the actions to take when one discovers one carries a genetic risk factor for cancer? UC San Francisco continues to be a resource for individuals who carry BRCA1 and BRCA2 mutations – those most commonly involved in Hereditary Breast and Ovarian Cancer (HBOC). Men and women with these genes have questions and concerns and are often interested in accessing resources – ranging from discussions with patients and health care professionals to understanding the landscape for trials.

The UCSF Department of Radiology and Biomedical Imaging teamed up with the UCSF Helen Diller Family Comprehensive Cancer Center and its Center for BRCA Research for a panel discussion with experts who offered valuable insights on diagnosing and treating hereditary cancers.

Featured on this video are Heather Greenwood, MD, assistant professor in breast imaging at UCSF; Alan Ashworth, PhD, FRS, president of the UCSF Helen Diller Family Comprehensive Cancer Center; Pamela Munster, MD, director of the Early Phase Clinical Trials Unit and co-leader of the Center for BRCA Research; Mindy Goldman, MD, professor of obstetrics and gynecology at UCSF; and Laura Holmes Haddad, breast cancer survivor and author of “This is Cancer: Everything You Need to Know from the Waiting Room to the Bedroom.”

The discourse surrounding this event, ‘Considering BRCA Genes: Knowledge Improves Outcomes,’ is ongoing. Collaborative efforts such as this one and future events will continue to spread the word on this crucial topic and help those in our community.